The contrast in results could also be due to the different cell types or the use of different HDAC substrates; previous studies used A549 lung carcinoma cells and primary glomerular mesangial cells, and all reported studies used the Fluor-De-Lys® HDAC Activity Assay Kit. The gene discussed is HDAC9; the disease is lung carcinoma.